{"id":2058,"date":"2022-08-11T21:28:00","date_gmt":"2022-08-12T04:28:00","guid":{"rendered":"https:\/\/www.penderventures.com\/?p=2058"},"modified":"2023-02-13T11:18:35","modified_gmt":"2023-02-13T19:18:35","slug":"nouvel-investissement-dans-evidence-partners","status":"publish","type":"post","link":"https:\/\/www.penderventures.com\/fr\/nouvel-investissement-dans-evidence-partners\/","title":{"rendered":"Nouvel investissement dans Evidence Partners"},"content":{"rendered":"\n

Nous sommes heureux de vous annoncer notre investissement dans Evidence Partners, chef de file sur le march\u00e9 des logiciels de recherche automatis\u00e9e par IA en mati\u00e8re de litt\u00e9rature scientifique, et fondateur de DistillerSR<\/a>MD<\/sup>. L\u2019entreprise a r\u00e9uni 20 millions $ au terme d\u2019une \u00e9tape de financement de croissance men\u00e9e par Thomvest Ventures avec la participation de Pender Ventures et d\u2019Exportation et d\u00e9veloppement Canada (EDC).<\/p>\n\n\n\n

Dans le domaine de la sant\u00e9, la recherche fond\u00e9e sur des donn\u00e9es probantes a \u00e9t\u00e9 instaur\u00e9e il y a plus de trente ans. On voulait ainsi que la prise de d\u00e9cision m\u00e9dicale s\u2019appuie davantage sur des recherches scientifiques et cliniquement pertinentes que sur l\u2019intuition et une exp\u00e9rience empirique. Les examens de la litt\u00e9rature servent aussi \u00e0 \u00e9clairer les d\u00e9cisions touchant au revenu et aux politiques de tous les secteurs de soins de sant\u00e9; de plus, elles sont requises pour les soumissions r\u00e9glementaires et les contr\u00f4les de s\u00e9curit\u00e9 des m\u00e9dicaments, des appareils m\u00e9dicaux et des autres produits devant \u00eatre approuv\u00e9s. Au-del\u00e0 des soins de sant\u00e9, elles sont aussi utiles aux organismes gouvernementaux \u2014 en alimentation, en sant\u00e9 et en environnement, entre autres \u2014 qui ont besoin de cet outil pour \u00e9tablir des plans d\u2019urgence, des politiques et des protocoles en pr\u00e9vision d\u2019une pand\u00e9mie ou d\u2019une catastrophe.<\/p>\n\n\n\n

Les chercheurs sont oblig\u00e9s de consulter de nombreuses sources (par exemple, les articles publi\u00e9s dans les revues m\u00e9dicales) pour r\u00e9unir les donn\u00e9es, les r\u00e9sultats et les conclusions fournis par des \u00e9tudes valides et dignes de confiance. Le nombre de donn\u00e9es ayant litt\u00e9ralement explos\u00e9, des millions d\u2019articles scientifiques sont publi\u00e9s chaque ann\u00e9e et des milliards de citations et de r\u00e9f\u00e9rences doivent \u00eatre pass\u00e9es au crible, ce qui fait de la revue de litt\u00e9rature une entreprise fastidieuse et chronophage. De plus, une r\u00e9glementation stricte exige que les revues de litt\u00e9rature fassent partie du processus d\u2019approbation des produits m\u00e9dicaux. Cela signifie que les organisations font face \u00e0 tout un d\u00e9fi pour garder leurs revues de litt\u00e9rature \u00e0 jour. Les chercheurs ont besoin d\u2019un outil qui r\u00e9duira le temps et le co\u00fbt associ\u00e9s \u00e0 la production de ces revues, et qui pourra am\u00e9liorer la qualit\u00e9, la transparence et la reproductibilit\u00e9 des donn\u00e9es.<\/p>\n\n\n\n

DistillerSR<\/a>MD<\/sup>, d\u2019Evidence Partners, automatise la gestion, la collecte, le tri et l\u2019analyse de la litt\u00e9rature gr\u00e2ce \u00e0 l\u2019AI et \u00e0 un flux de travail intelligent. Evidence Partners, parce qu\u2019elle automatise de fa\u00e7on syst\u00e9matique les revues, permet aux chercheurs en sant\u00e9 de prendre des d\u00e9cisions plus \u00e9clair\u00e9es et parfois urgentes sur les politiques, les protocoles et les soumissions obligatoires en mati\u00e8re de sant\u00e9, tout en leur donnant les moyens d\u2019am\u00e9liorer la qualit\u00e9 globale de leurs recherches.<\/p>\n\n\n\n

Evidence Partners jouit d\u2019une client\u00e8le diversifi\u00e9e et internationale de premier plan qui comprend des institutions universitaires, six des dix plus importantes entreprises d\u2019appareils m\u00e9dicaux, six des dix principales entreprises pharmaceutiques, plus de 25 organismes gouvernementaux aux \u00c9tats-Unis, en Europe et au Canada, et plus de 40 organismes de recherche sous contrat.<\/p>\n\n\n\n

L\u2019origine de l\u2019entreprise remonte \u00e0 2008, alors que ses co-fondateurs, Peter O\u2019Blenis, Ian Stefanison et Jonathan Barker, travaillaient pour le Centre hospitalier pour enfants de l\u2019est de l\u2019Ontario, qui est affili\u00e9 \u00e0 l\u2019Institut de recherche de l\u2019H\u00f4pital d\u2019Ottawa et \u00e0 l\u2019Universit\u00e9 d\u2019Ottawa. \u00c0 cette \u00e9poque, les co-fondateurs travaillaient pour une autre entreprise naissante, TrialStat, qui \u00e9tait en train d\u2019\u00e9laborer une plate-forme \u00e9lectronique destin\u00e9e \u00e0 g\u00e9rer les donn\u00e9es cliniques des patients participant \u00e0 des essais sur des m\u00e9dicaments. Alors qu\u2019ils collaboraient avec certains des plus grands sp\u00e9cialistes en revues de litt\u00e9rature, ils ont d\u00e9couvert que les chercheurs utilisaient encore tr\u00e8s largement Excel et la m\u00e9thode papier, et souhaitaient ardemment trouver une meilleure fa\u00e7on de faire leurs revues. Cette d\u00e9couverte a jet\u00e9 les bases du prototype de DistillerSR<\/a>MD<\/sup> et de la cr\u00e9ation d\u2019Evidence Partners.<\/p>\n\n\n\n

Evidence Partners cadre avec la mission de notre fonds qui est ax\u00e9 sur la centralisation des donn\u00e9es gr\u00e2ce aux technologies de l\u2019information en sant\u00e9 permettant aux professionnels de prendre des d\u00e9cisions plus \u00e9clair\u00e9es. En tant qu\u2019investisseurs privil\u00e9giant le secteur des technologies de l\u2019information en sant\u00e9, nous saisissons pleinement \u00e0 quel point le domaine des donn\u00e9es m\u00e9dicales repr\u00e9sente tant un d\u00e9fi qu\u2019une occasion. Le personnel soignant et les innovateurs ont besoin non seulement de donn\u00e9es robustes et fiables, mais \u00e9galement d\u2019un march\u00e9 accessible dont les utilisateurs finaux sont dispos\u00e9s \u00e0 accueillir le changement et \u00e0 adopter une nouvelle technologie.<\/p>\n\n\n\n

Nous sommes ravis de nous associer \u00e0 l\u2019\u00e9quipe d\u2019Evidence Partners, qui se consacre \u00e0 r\u00e9soudre les probl\u00e8mes de leurs clients dans un domaine qui a une incidence cruciale sur les soins de sant\u00e9 et sur d\u2019autres secteurs essentiels.<\/p>\n","protected":false},"excerpt":{"rendered":"

Nous sommes heureux de vous annoncer notre investissement dans Evidence Partners, chef de file sur le march\u00e9 des logiciels de recherche automatis\u00e9e par IA en mati\u00e8re de litt\u00e9rature scientifique, et fondateur de DistillerSRMD. L\u2019entreprise a r\u00e9uni 20 millions $ au terme d\u2019une \u00e9tape de financement de croissance men\u00e9e par Thomvest Ventures avec la participation de Pender Ventures […]<\/p>\n","protected":false},"author":10,"featured_media":1367,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-2058","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites-opinions"],"yoast_head":"\nNouvel investissement dans Evidence Partners - Pender Ventures<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nouvel investissement dans Evidence Partners - Pender Ventures\" \/>\n<meta property=\"og:description\" content=\"Nous sommes heureux de vous annoncer notre investissement dans Evidence Partners, chef de file sur le march\u00e9 des logiciels de recherche automatis\u00e9e par IA en mati\u00e8re de litt\u00e9rature scientifique, et fondateur de DistillerSRMD. L\u2019entreprise a r\u00e9uni 20 millions $ au terme d\u2019une \u00e9tape de financement de croissance men\u00e9e par Thomvest Ventures avec la participation de Pender Ventures […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/\" \/>\n<meta property=\"og:site_name\" content=\"Pender Ventures\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-12T04:28:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-13T19:18:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.penderventures.com\/wp-content\/uploads\/2022\/06\/christopher-burns-Kj2SaNHG-hg-unsplash-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pender Ventures\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@penderventures\" \/>\n<meta name=\"twitter:site\" content=\"@penderventures\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pender Ventures\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/\"},\"author\":{\"name\":\"Pender Ventures\",\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/#\\\/schema\\\/person\\\/7163f65a5853a1700d4ecaacc2c99dc2\"},\"headline\":\"Nouvel investissement dans Evidence Partners\",\"datePublished\":\"2022-08-12T04:28:00+00:00\",\"dateModified\":\"2023-02-13T19:18:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/\"},\"wordCount\":860,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.penderventures.com\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/christopher-burns-Kj2SaNHG-hg-unsplash-scaled.jpg\",\"articleSection\":[\"Actualit\u00e9s et opinions\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/\",\"url\":\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/\",\"name\":\"Nouvel investissement dans Evidence Partners - Pender Ventures\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.penderventures.com\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/christopher-burns-Kj2SaNHG-hg-unsplash-scaled.jpg\",\"datePublished\":\"2022-08-12T04:28:00+00:00\",\"dateModified\":\"2023-02-13T19:18:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.penderventures.com\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/christopher-burns-Kj2SaNHG-hg-unsplash-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.penderventures.com\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/christopher-burns-Kj2SaNHG-hg-unsplash-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/announcing-our-investment-in-evidence-partners\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.penderventures.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nouvel investissement dans Evidence Partners\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/#website\",\"url\":\"https:\\\/\\\/www.penderventures.com\\\/\",\"name\":\"Pender Ventures\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.penderventures.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/#organization\",\"name\":\"Pender Ventures\",\"url\":\"https:\\\/\\\/www.penderventures.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.penderventures.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/2020_Pender_Ventures_SecondaryHoriz_Eng-e1666819861664.png\",\"contentUrl\":\"https:\\\/\\\/www.penderventures.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/2020_Pender_Ventures_SecondaryHoriz_Eng-e1666819861664.png\",\"width\":978,\"height\":127,\"caption\":\"Pender Ventures\"},\"image\":{\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/penderventures\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pender-ventures\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.penderventures.com\\\/#\\\/schema\\\/person\\\/7163f65a5853a1700d4ecaacc2c99dc2\",\"name\":\"Pender Ventures\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b64e243c6a00265f06cfcbe17a6c0a9380934b14557712ea0c0f4a41821361c3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b64e243c6a00265f06cfcbe17a6c0a9380934b14557712ea0c0f4a41821361c3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b64e243c6a00265f06cfcbe17a6c0a9380934b14557712ea0c0f4a41821361c3?s=96&d=mm&r=g\",\"caption\":\"Pender Ventures\"},\"url\":\"https:\\\/\\\/www.penderventures.com\\\/fr\\\/author\\\/penderventures\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nouvel investissement dans Evidence Partners - Pender Ventures","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/","og_locale":"fr_FR","og_type":"article","og_title":"Nouvel investissement dans Evidence Partners - Pender Ventures","og_description":"Nous sommes heureux de vous annoncer notre investissement dans Evidence Partners, chef de file sur le march\u00e9 des logiciels de recherche automatis\u00e9e par IA en mati\u00e8re de litt\u00e9rature scientifique, et fondateur de DistillerSRMD. L\u2019entreprise a r\u00e9uni 20 millions $ au terme d\u2019une \u00e9tape de financement de croissance men\u00e9e par Thomvest Ventures avec la participation de Pender Ventures […]","og_url":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/","og_site_name":"Pender Ventures","article_published_time":"2022-08-12T04:28:00+00:00","article_modified_time":"2023-02-13T19:18:35+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.penderventures.com\/wp-content\/uploads\/2022\/06\/christopher-burns-Kj2SaNHG-hg-unsplash-scaled.jpg","type":"image\/jpeg"}],"author":"Pender Ventures","twitter_card":"summary_large_image","twitter_creator":"@penderventures","twitter_site":"@penderventures","twitter_misc":{"\u00c9crit par":"Pender Ventures","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/#article","isPartOf":{"@id":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/"},"author":{"name":"Pender Ventures","@id":"https:\/\/www.penderventures.com\/#\/schema\/person\/7163f65a5853a1700d4ecaacc2c99dc2"},"headline":"Nouvel investissement dans Evidence Partners","datePublished":"2022-08-12T04:28:00+00:00","dateModified":"2023-02-13T19:18:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/"},"wordCount":860,"commentCount":0,"publisher":{"@id":"https:\/\/www.penderventures.com\/#organization"},"image":{"@id":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/#primaryimage"},"thumbnailUrl":"https:\/\/www.penderventures.com\/wp-content\/uploads\/2022\/06\/christopher-burns-Kj2SaNHG-hg-unsplash-scaled.jpg","articleSection":["Actualit\u00e9s et opinions"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/","url":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/","name":"Nouvel investissement dans Evidence Partners - Pender Ventures","isPartOf":{"@id":"https:\/\/www.penderventures.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/#primaryimage"},"image":{"@id":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/#primaryimage"},"thumbnailUrl":"https:\/\/www.penderventures.com\/wp-content\/uploads\/2022\/06\/christopher-burns-Kj2SaNHG-hg-unsplash-scaled.jpg","datePublished":"2022-08-12T04:28:00+00:00","dateModified":"2023-02-13T19:18:35+00:00","breadcrumb":{"@id":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/#primaryimage","url":"https:\/\/www.penderventures.com\/wp-content\/uploads\/2022\/06\/christopher-burns-Kj2SaNHG-hg-unsplash-scaled.jpg","contentUrl":"https:\/\/www.penderventures.com\/wp-content\/uploads\/2022\/06\/christopher-burns-Kj2SaNHG-hg-unsplash-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/www.penderventures.com\/announcing-our-investment-in-evidence-partners\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.penderventures.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Nouvel investissement dans Evidence Partners"}]},{"@type":"WebSite","@id":"https:\/\/www.penderventures.com\/#website","url":"https:\/\/www.penderventures.com\/","name":"Pender Ventures","description":"","publisher":{"@id":"https:\/\/www.penderventures.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.penderventures.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.penderventures.com\/#organization","name":"Pender Ventures","url":"https:\/\/www.penderventures.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.penderventures.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.penderventures.com\/wp-content\/uploads\/2022\/10\/2020_Pender_Ventures_SecondaryHoriz_Eng-e1666819861664.png","contentUrl":"https:\/\/www.penderventures.com\/wp-content\/uploads\/2022\/10\/2020_Pender_Ventures_SecondaryHoriz_Eng-e1666819861664.png","width":978,"height":127,"caption":"Pender Ventures"},"image":{"@id":"https:\/\/www.penderventures.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/penderventures","https:\/\/www.linkedin.com\/company\/pender-ventures"]},{"@type":"Person","@id":"https:\/\/www.penderventures.com\/#\/schema\/person\/7163f65a5853a1700d4ecaacc2c99dc2","name":"Pender Ventures","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/b64e243c6a00265f06cfcbe17a6c0a9380934b14557712ea0c0f4a41821361c3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b64e243c6a00265f06cfcbe17a6c0a9380934b14557712ea0c0f4a41821361c3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b64e243c6a00265f06cfcbe17a6c0a9380934b14557712ea0c0f4a41821361c3?s=96&d=mm&r=g","caption":"Pender Ventures"},"url":"https:\/\/www.penderventures.com\/fr\/author\/penderventures\/"}]}},"jetpack_featured_media_url":"https:\/\/www.penderventures.com\/wp-content\/uploads\/2022\/06\/christopher-burns-Kj2SaNHG-hg-unsplash-scaled.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.penderventures.com\/fr\/wp-json\/wp\/v2\/posts\/2058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.penderventures.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.penderventures.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.penderventures.com\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.penderventures.com\/fr\/wp-json\/wp\/v2\/comments?post=2058"}],"version-history":[{"count":1,"href":"https:\/\/www.penderventures.com\/fr\/wp-json\/wp\/v2\/posts\/2058\/revisions"}],"predecessor-version":[{"id":2059,"href":"https:\/\/www.penderventures.com\/fr\/wp-json\/wp\/v2\/posts\/2058\/revisions\/2059"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.penderventures.com\/fr\/wp-json\/wp\/v2\/media\/1367"}],"wp:attachment":[{"href":"https:\/\/www.penderventures.com\/fr\/wp-json\/wp\/v2\/media?parent=2058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.penderventures.com\/fr\/wp-json\/wp\/v2\/categories?post=2058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.penderventures.com\/fr\/wp-json\/wp\/v2\/tags?post=2058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}